India  

Zimbabwe first in Africa to OK Covaxin

IndiaTimes Friday, 5 March 2021
0
shares
ShareTweetSavePostSend
 

💡 newsR Knowledge: Other News Mentions

Zimbabwe Zimbabwe Country in Southern Africa

Zimbabwe: Dwindling blood supplies prompt calls for donors [Video]

Zimbabwe: Dwindling blood supplies prompt calls for donors

Government-enforced COVID-19 lockdowns and restrictions on movement have led to fewer people donating blood.

Credit: Al Jazeera STUDIO    Duration: 02:06Published
Zimbabwe: Easing COVID-19 restrictions brings hope to businesses [Video]

Zimbabwe: Easing COVID-19 restrictions brings hope to businesses

Why businesses in Zimbabwe say the easing of coronavirus restrictions may do little to help them recover.

Credit: Al Jazeera STUDIO    Duration: 02:09Published
Stephanie Travers: From Zimbabwe to an F1 podium [Video]

Stephanie Travers: From Zimbabwe to an F1 podium

From Zimbabwe to the podium, Mercedes AMG Petronas engineer Stephanie Travers tells Amanda Davies about the emotional feeling she felt standing on the podium, spraying Lewis Hamilton with champagne after his win at the Styrian Grand Prix last year.

Credit: Bleacher Report AOL    Duration: 03:27Published
COVID-19 curbs threaten Zimbabwe’s trophy hunting industry [Video]

COVID-19 curbs threaten Zimbabwe’s trophy hunting industry

A knock on effect of the pandemic - taxidermists feel the economic pinch in Zimbabwe now that big game hunting is all but shut down.

Credit: Al Jazeera STUDIO    Duration: 02:11Published
Inspiring the next generation of space enthusiasts in Zimbabwe [Video]

Inspiring the next generation of space enthusiasts in Zimbabwe

Ruvimbo Samanga never thought her passion for law and love of space could combine into one career. Now, she’s using her experience to inspire kids in Zimbabwe to reach for the stars.

Credit: Bleacher Report AOL    Duration: 03:13Published

BBV152 BBV152 Vaccine against COVID-19

Use entire national capacity to step up Covid vaccine production, PM tells officials

The PM’s directive came at a review meeting on the Covid situation on Saturday a day after he had overseen an assessment of oxygen supplies and production and..
IndiaTimes

Covaxin production to be increased to 100 million doses per month by September 2021: Centre

Union health minister Harsh Vardhan said financial support is being provided to four manufacturers to expand Covaxin vaccine production.
DNA

India to increase Covaxin production to 100 million doses per month by September

The Union government on Friday said it will amp up the production of the indigenously developed Covaxin vaccine to 100 million doses per month by September. As..
IndiaTimes
Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin [Video]

Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin

The Central Government has given permission to Haffkine Institute to produce Bharat Biotech's Covaxin. CM Uddhav Thackeray thanked PM Modi through a tweet by CM office, Maharashtra on April 15, "The Dept of Science and Technology, Government of India, has granted approval to Haffkine Institute to produce Bharat Biotech's Covaxin vaccine on a transfer of technology basis. CM Uddhav Balasaheb Thackeray has thanked the Hon'ble PM Shri@narendramodi for approving this request."

Credit: ANI    Duration: 01:14Published

You Might Like


Related news from verified sources

Covishield or Covaxin: Mutant strains in some West Bengal patients raise concerns over vaccine efficacy

The detection of double mutant Covid strain in some Bengal patients has left experts and those waiting to get vaccinated worried about the efficacy of...
IndiaTimes

Covaxin out of clinical trial mode, granted restricted emergency use authorisation

The Centre on Thursday said Bharat Biotech's indigenously developed Covaxin is out of the "clinical trial mode" and that it has now been granted the regular...
IndiaTimes

'Powerful example for all Indians': Bharat Biotech after PM Modi takes Covaxin shot

Prime Minister Narendra Modi on Monday (March 1) was administered the first dose of COVID-19 vaccine, Covaxin at the AIIMS, Delhi.
DNA